QAM
GILD icon

Q3 Asset Management’s Gilead Sciences GILD Stock Holding History

Q3 Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-31,125
Closed -$3.48M – 61
2025
Q1 		$3.48M Buy
+31,125
New +$3.21M 2.38% 13
2023
Q3 		– Sell
-22,493
Closed -$1.73M – 54
2023
Q2 		$1.73M Buy
22,493
+9,746
+76% +$777K 0.84% 23
2023
Q1 		$1.06M Buy
12,747
+8,933
+234% +$740K 0.88% 27
2022
Q4 		$325K Buy
+3,814
New +$302K 0.22% 39

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Q3 Asset Management's GILD Position: Q2 2025 in Review

Q3 Asset Management sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 31,125 shares — an estimated $3.48M sold.

Q3 Asset Management first reported a position in GILD in Q4 2022 and held it in 4 quarters. The position peaked at $3.48M in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Q3 Asset Management reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Q3 Asset Management sold 31,125 Gilead Sciences shares in Q2 2025, an estimated $3.48M.
  • Q3 Asset Management first reported a position in Gilead Sciences in Q4 2022 and held it in 4 quarters.
  • Q3 Asset Management's Gilead Sciences position peaked at $3.48M in Q1 2025.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Q3 Asset Management's 13F filing for Q2 2025, filed 3 Sep 2025.